Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

Br J Haematol. 2011 Oct;155(2):274-7. doi: 10.1111/j.1365-2141.2011.08675.x. Epub 2011 Apr 13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Comparative Genomic Hybridization
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Genes, myc*
  • Humans
  • Kaplan-Meier Estimate
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Prednisone / administration & dosage
  • Prognosis
  • Rituximab
  • Treatment Outcome
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol